Adolor Corporation Earnings Conference Call (Q3 2009)  Today's Calls

Visit the TF Network Sites· Corporate IR Center · Institutional Investor Center · Individual Investor Center Download Plug-In Real Player 8 Basic Windows Media Player Other Conference Calls Other Oct 29 Calls Today's Calls

Call Details Adolor Corporation Earnings Conference Call (Q3 2009) Thu, Oct 29, 2009, 8:45 am Eastern Listen to the archived event audio About Adolor Corporation (NasdaqGM:ADLR) Adolor Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of prescription pain management products. Its product includes ENTEREG (alvimopan), a small molecule peripherally-acting mu-opioid receptor antagonist designed to block the adverse side effects of opioid analgesics on the gastrointestinal tract, as well as for the management of postoperative ileus following bowel resection surgery that causes significant discomfort for patients. The company’s product candidates in various stages of clinical and preclinical development include two novel delta opioid receptor agonists that are in mid-stage clinical development in collaboration with Pfizer Inc. for chronic pain; a mu opioid receptor antagonist entering development for chronic OBD; and various opioid and non-opioid discovery programs. Adolor Corporation was founded in 1993 and is headquartered in Exton, Pennsylvania. More Info: Quote | Chart | News | Profile | Reports | Research | SEC | Msgs | Insider | Financials | Analyst Ratings